141 related articles for article (PubMed ID: 31215288)
1. Phytosterols and triterpenes from
Adewole KE; Ishola AA
J Recept Signal Transduct Res; 2019 Feb; 39(1):87-97. PubMed ID: 31215288
[TBL] [Abstract][Full Text] [Related]
2. Phytosterols and triterpenes from Morinda lucida Benth. exhibit binding tendency against class I HDAC and HDAC7 isoforms.
Ishola AA; Adewole KE
Mol Biol Rep; 2019 Apr; 46(2):2307-2325. PubMed ID: 30771146
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.
Richard DJ; Lena R; Bannister T; Blake N; Pierceall WE; Carlson NE; Keller CE; Koenig M; He Y; Minond D; Mishra J; Cameron M; Spicer T; Hodder P; Cardone MH
Bioorg Med Chem; 2013 Nov; 21(21):6642-9. PubMed ID: 23993674
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins.
Mohamad Rosdi MN; Mohd Arif S; Abu Bakar MH; Razali SA; Mohamed Zulkifli R; Ya'akob H
Apoptosis; 2018 Jan; 23(1):27-40. PubMed ID: 29204721
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel potent inhibitors against Bcl-xL anti-apoptotic protein using docking studies.
Shipra G; Gauri M; Chandra PM; Kishore SP
Protein Pept Lett; 2012 Dec; 19(12):1302-17. PubMed ID: 22670675
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as Bcl-2/Mcl-1 inhibitors.
Liu R; Liu L; Yang X; Fang H
Bioorg Chem; 2019 Jul; 88():102938. PubMed ID: 31028992
[TBL] [Abstract][Full Text] [Related]
8. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
Inoue-Yamauchi A; Jeng PS; Kim K; Chen HC; Han S; Ganesan YT; Ishizawa K; Jebiwott S; Dong Y; Pietanza MC; Hellmann MD; Kris MG; Hsieh JJ; Cheng EH
Nat Commun; 2017 Jul; 8():16078. PubMed ID: 28714472
[TBL] [Abstract][Full Text] [Related]
9. Development of an efficient route toward meiogynin A-inspired dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.
Desrat S; Remeur C; Roussi F
Org Biomol Chem; 2015 May; 13(19):5520-31. PubMed ID: 25877523
[TBL] [Abstract][Full Text] [Related]
10. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X
Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R
Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015
[TBL] [Abstract][Full Text] [Related]
11. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
[TBL] [Abstract][Full Text] [Related]
12. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
Liu R; Liu L; Liu T; Yang X; Wan Y; Fang H
Bioorg Med Chem; 2018 Sep; 26(17):4907-4915. PubMed ID: 30170927
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.
Li R; Cheng C; Balasis ME; Liu Y; Garner TP; Daniel KG; Li J; Qin Y; Gavathiotis E; Sebti SM
Eur J Med Chem; 2015 Jan; 90():315-331. PubMed ID: 25437618
[TBL] [Abstract][Full Text] [Related]
14. Flexibility enables to discriminate between ligands: Lessons from structural ensembles of Bcl-xl and Mcl-1.
Maity A; Majumdar S; Ghosh Dastidar S
Comput Biol Chem; 2018 Dec; 77():17-27. PubMed ID: 30195235
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.
Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L
Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472
[TBL] [Abstract][Full Text] [Related]
16. From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.
Desrat S; Remeur C; Gény C; Rivière G; Colas C; Dumontet V; Birlirakis N; Iorga BI; Roussi F
Chem Commun (Camb); 2014 Aug; 50(62):8593-6. PubMed ID: 24956071
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors.
Fu H; Hou X; Wang L; Dun Y; Yang X; Fang H
Bioorg Med Chem Lett; 2015 Nov; 25(22):5265-9. PubMed ID: 26421995
[TBL] [Abstract][Full Text] [Related]
18. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.
Hedir S; De Giorgi M; Fogha J; De Pascale M; Weiswald LB; Brotin E; Marekha B; Denoyelle C; Denis C; Suzanne P; Gautier F; Juin P; Ligat L; Lopez F; Carlier L; Legay R; Bureau R; Rault S; Poulain L; Oliveira Santos JS; Voisin-Chiret AS
Eur J Med Chem; 2018 Nov; 159():357-380. PubMed ID: 30308410
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the stereochemical structures of 2H-thiazolo[3,2-a]pyrimidine compounds and their binding affinities for anti-apoptotic Bcl-2 family proteins.
Xu Y; Zhou M; Li Y; Li C; Zhang Z; Yu B; Wang R
ChemMedChem; 2013 Aug; 8(8):1345-52. PubMed ID: 23794243
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng.
Sathishkumar N; Sathiyamoorthy S; Ramya M; Yang DU; Lee HN; Yang DC
J Enzyme Inhib Med Chem; 2012 Oct; 27(5):685-92. PubMed ID: 21919598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]